Status:

COMPLETED

Identification of the Best Self-questionnaire to Diagnose Depression in Patients With Psoriasis (DePsoVal)

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Psoriasis

Depression

Eligibility:

All Genders

18-65 years

Brief Summary

Prevalence of depression shows great heterogeneity in patients with psoriasis. This could be explained by the psychometric properties of the questionnaires assessing depressive symptoms: these tests h...

Detailed Description

The study does not modify the management of patients. Patients will be contacted by phone. The protocol, the modalities and the objectives of the study will be presented during a first telephone inter...

Eligibility Criteria

Inclusion

  • Major patient, male or female, with psoriasis, less than 65 years old, followed up in the dermatology or rheumatology departments of the University Hospital of Clermont-Ferrand.
  • Able to mentally and linguistically answer the proposed questionnaires.
  • Can fill out online questionnaires from his home.
  • Affiliated with Social Security.

Exclusion

  • Major incapable patient
  • Refusal of participation

Key Trial Info

Start Date :

July 22 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 7 2021

Estimated Enrollment :

289 Patients enrolled

Trial Details

Trial ID

NCT04013867

Start Date

July 22 2019

End Date

June 7 2021

Last Update

July 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Clermont-Ferrand

Clermont-Ferrand, France, 63000

Identification of the Best Self-questionnaire to Diagnose Depression in Patients With Psoriasis (DePsoVal) | DecenTrialz